Advertisement

Psychiatrische Aspekte des Morbus Parkinson und anderer neurologischer Erkrankungen

  • J. Cutting

Zusammenfassung

Das Vorhandensein einer körperlichen Krankheit erhöht das Risiko für eine psychiatrische Störung. Dies wurde in zahlreichen Untersuchungen dargestellt. Neurologische Erkrankungen bilden hierbei keine Ausnahme. In einer Untersuchung von 342 ambulanten neurologischen Patienten eines nordenglischen Krankenhauses wurden beispielsweise bei 48% pathologisch hohe Werte im Goldberg Fragebogen für neurotische Symptome ermittelt (Kirk u. Saunders 1979).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH (1965) Symptomatic occult hydrocephalus with “normal” cerebrospinal fluid pressure. N Engl J Med 273:117–126PubMedGoogle Scholar
  2. Albert ML, Feldman RG, Willis AL (1974) The subcortical dementia aof progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37:121–130PubMedGoogle Scholar
  3. Baker L, Cheng LY, Amara IB (1983) The withdrawal of benztropine mesylate in chronic schizophrenic patients. Br J Psychiatry 143:584–590PubMedGoogle Scholar
  4. Bankier RG (1985) Third ventricle size and dementia in schizophrenia. Br J Psychiatry 147:241–245PubMedGoogle Scholar
  5. Barabas G, Matthews WS, Ferrari M (1984) Disorders of arousal in Gilles de la Tourette’s syndrome. Neurology 34:815–817PubMedGoogle Scholar
  6. Barette J, Marsden CD (1979) Attitudes of families to some aspects of Huntington’s chorea. Psychol Med 9:327–336PubMedGoogle Scholar
  7. Beard AW (1959) The association of hepatolenticular degeneration with schizophrenia. Acta Psychiatr Scand 34:411–428PubMedGoogle Scholar
  8. Bindman E, Tibbetts RW (1977) Writer’s cramp — a rational approach to treatment. Br J Psychiatry 131:143–148PubMedGoogle Scholar
  9. Bleich A, Bernout E, Apter A, Tyano S (1985) Gilles de la Tourette syndrome and mania in an adolescent. Br J Psychiatry 146:664–665PubMedGoogle Scholar
  10. Boller F, Mizutani T, Roessmann U, Gambetti P (1980) Parkinson disease, dementia and Alzheimer disease: clinicopathological correlations. Ann Neurol 7:329–335PubMedGoogle Scholar
  11. Bowers MB, Woert M van, Davis L (1971) Sexual behaviour during L-dopa treatment for Parkinsonism. Am J Psychiatry 127:1691–1693PubMedGoogle Scholar
  12. Brown JH, Paraskevas F (1982) Cancer and depression: cancer presenting with depressive illness: an autoimmune disease? Br J Psychiatry 141:227–232PubMedGoogle Scholar
  13. Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J (1982) Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 32:1335–1346PubMedGoogle Scholar
  14. Butters N, Tarlow S, Cermak LS, Sax D (1976) A comparison of the information processing deficits of patients with Huntington’s chorea and KorsakofFs syndrome. Cortex 12:134–144PubMedGoogle Scholar
  15. Caine ED (1985) Gilles de la Tourettès syndrome. Arch Neurol 42:393–397PubMedGoogle Scholar
  16. Caine ED, Shoulson I (1983) Psychiatrie syndromes in Huntington’s disease. Am J Psychiatry 140:728–733Google Scholar
  17. Cartwright GE (1978) Diagnosis of treatable Wilsons disease. N Engl J Med 298:1347–1350PubMedGoogle Scholar
  18. Celesia GG, Barr AN (1970) Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol 23:193–200PubMedGoogle Scholar
  19. Celesia GG, Wanamaker WM (1972) Psychiatric disturbances in Parkinson’s disease. Dis Nerv Syst 9:577–583Google Scholar
  20. Charatan FB, Brierley JB (1956) Mental disorder associated with primary lung carcinoma. Br Med J 1:765–768PubMedGoogle Scholar
  21. Cockburn JJ (1971) Spasmodic torticollis: a psychogenic condition. J Psychosom Res 15:471–477PubMedGoogle Scholar
  22. Connell PH, Corbett JA, Mathews AM, Hörne DJ (1967) Drug treatment of adolescent ticqueurs: a double blind trial of diazepam and haloperidol. Br J Psychiatry 113:375–381PubMedGoogle Scholar
  23. Corbett JA, Mathews AM, Connell PH, Shapiro DA (1969) Tics and Gilles de la Tourettès syndrome: a follow-up study and critical review. Br J Psychiatry 115:1229–1241PubMedGoogle Scholar
  24. Corsellis JAN, Goldberg GJ, Norton AR (1968) Limbic encephalitis and its association with carcinoma. Brain 91:481–496PubMedGoogle Scholar
  25. Cotzias GC, Woert MH van, Schiffer LM (1967) Aromatic amino acids and modification of Parkinsonism. N Engl J Med 276:374–380PubMedGoogle Scholar
  26. Crawshaw JA, Mullen PE (1984) A study of benzhexol abuse. Br J Psychiatry 145:300–303PubMedGoogle Scholar
  27. Crow TJ, Ferrier IN, Johnstone EC, Macmillan JF, Owens DGC, Parry RD et al. (1976) The coincidence of schizophrenia and Parkinsonism: some neurochemical implications. Psychol Med 6:227–233PubMedGoogle Scholar
  28. Cutting J (1980) Physical illness and psychosis. Br J Psychiatry 136:109–119PubMedGoogle Scholar
  29. Cutting J (1985) The psychology of schizophrenia. Churchill Livingstone, EdinburghGoogle Scholar
  30. Cutting J (1986) The phenomenology of acute organic psychosis: comparison with acute schizophrenia. Br J Psychiatry (in press)Google Scholar
  31. Damasio AR, Lobo-Antunes J, Macedo C (1971) Psychiatric aspects in Parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry 34:502–507PubMedGoogle Scholar
  32. David NJ, Macey EA, Smith JL (1968) Further observations in progressive supranuclear palsy. Neurology 18:349–356PubMedGoogle Scholar
  33. Davison K, Bagley CR (1969) Schizophrenia — like psychoses associated with organic disorders of the central nervous system: a review of the literature. In: Herrington RN (ed) Current problems in neuropsychiatry. Headley, Ashford, KentGoogle Scholar
  34. Dening TR (1985) Psychiatric aspects of Wilsons disease. Br J Psychiatry 147:677–682PubMedGoogle Scholar
  35. Dennis M (1981) Language in a congenitally acallosal brain. Brain Lang 12:33–53PubMedGoogle Scholar
  36. Devinsky O (1983) Neuroanatomy of Gilles de la Tourettès syndrome. Possible midbrain involvement. Arch Neurol 40:508–514PubMedGoogle Scholar
  37. Dewhurst K, Oliver JE, McKnight AL (1970) Socio-psychiatric consequences of Huntingtons disease. Br J Psychiatry 116:255–258PubMedGoogle Scholar
  38. Duvoisin RC, Eldridge R, Williams A, Nutt J, Calne D (1981) Twin study of Parkinson disease. Neurology 31:77–80PubMedGoogle Scholar
  39. Ecónomo C von (1917) Encephalitis lethargica. Wien Klin Wochenschr 30:581Google Scholar
  40. Eldrige R (1970) The torsion dystonias: literature review and genetic and clinical studies. Neurology 20(11/2): 1–78Google Scholar
  41. Elizan TS, Hirano A, Abrams BM, Need RL, Nuis C van, Kurland LT (1966) Amyotrophic lateral sclerosis and Parkinsonism — dementia complex of Guam. Arch Neurol 14:356–368PubMedGoogle Scholar
  42. Fisk JD, Goodale MA, Burkhart G, Barnett HJM (1982) Progressive supranuclear palsy: the relationship between ocular motor dysfunction and psychological test performance. Neurology 32:698–705PubMedGoogle Scholar
  43. Flaherty JA, Bellur SN (1981) Mental side effects of amantidine therapy: its spectrum and characteristics in a normal population. J Clin Psychiatry 42:344–345PubMedGoogle Scholar
  44. Flowers KA, Robertson C (1985) The effect of Parkinson’s disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry 48:517–529Google Scholar
  45. Folstein MF, McHugh PR (1983) The neuropsychiatry of some specific brain disorders. In: Lader MH (ed) Handbook of psychiatry, vol 2. Mental disorders and somatic illness. Cambridge University Press, Cambridge, pp 107–118Google Scholar
  46. Folstein SE, Abbott MH, Chase GA, Jensen BA, Folstein MF (1983) The association of affective disorder with Huntington’s disease in a case series and in families. Psychol Med 13:537–542PubMedGoogle Scholar
  47. Francis AF (1979) Familial basal ganglia calcification and schizophreniform psychosis. Br J Psychiatry 135:360–362PubMedGoogle Scholar
  48. Fras I, Litin EM, Pearson JS (1967) Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry 123:1553–1562PubMedGoogle Scholar
  49. Frith CD (1984) Schizophrenia, memory and anticholinergic drugs. J Abnorm Psychol 93:339–341PubMedGoogle Scholar
  50. Garruto RM, Yanagihara R, Gajdusek DC (1985) Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 35:193–198PubMedGoogle Scholar
  51. Gilles de la Tourette (1885) Étude sur une affection nerveuse caractérisée par de l’incoordination motrice accompagnée d’écholalie et de coprolalie. Arch Neurol 9:19–42,158–200Google Scholar
  52. Glaze DG, Frost JD, Jankovic J (1983) Sleep in Gilles de la Tourettès syndrome: disorder of arousal. Neurology 33:586–592PubMedGoogle Scholar
  53. Goetz CG, Tanner CM, Klawans HL (1982) Pharmacology of hallucinations induced by longterm drug therapy. Am J Psychiatry 139:494–497PubMedGoogle Scholar
  54. Goodwin FK (1971) Behavioural effects of L-dopa in man. Sem Psychiatr 3:477–492Google Scholar
  55. Greenberg D, Marks I (1982) Behavioural psychotherapy of uncommon referrals. Br J Psychiatry 141:148–153PubMedGoogle Scholar
  56. Gusella JF, Wexler NS, Coneally PM et al. (1983) A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306:234–238Google Scholar
  57. Hakim AM, Mathieson G (1978) Basis of dementia in Parkinson’s disease. Lancet 11:729Google Scholar
  58. Hakim S, Adams RD (1965) The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. J Neurol Sci 2:307–327PubMedGoogle Scholar
  59. Hardie RJ, Lees A J, Stern GM (1984) On-off fluctuations in Parkinson’s disease. Brain 107:487–506PubMedGoogle Scholar
  60. Heathfield KWG (1967) Huntington’s chorea. Brain 90:203–232PubMedGoogle Scholar
  61. Henson R, Urich H (1982) Cancer and the nervous system. Blackwell, OxfordGoogle Scholar
  62. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMedGoogle Scholar
  63. Horn S (1974) Some psychological factors in Parkinsonism. J Neurol Neurosurg Psychiatry 37:27–31PubMedGoogle Scholar
  64. Hornykiewicz O (1963) Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin in der substantia nigra des normalen und parkinsonkranken Menschen. Wien Klin Wochenschr 75:309–312PubMedGoogle Scholar
  65. Huntington G (1872) On chorea. Med Surg Reports (Philadelphia) 26:317–321Google Scholar
  66. Jankovic J, Glaze DG, Frost JD (1984) Effect of tetrabenazine on tics and sleep of Gilles de la Tourette’s syndrome. Neurology 34:688–692PubMedGoogle Scholar
  67. Jewesbury ECO (1968) Involuntary movements. Hosp Med 1187–1197Google Scholar
  68. Josiassen RC, Curry LM, Mancall EL (1983) Development of neuropsychological deficits in Huntingtons disease. Arch Neurol 40:791–796PubMedGoogle Scholar
  69. Kirk CA, Saunders M (1979) Psychiatric illness in a neurological out-patient department in North East England. Acta Psychiatr Scand 60:427–437PubMedGoogle Scholar
  70. Klawans HL, Goetz CG, Paulson GW, Barbeau A (1980) Levodopa and presymptomatic detection of Huntington’s disease: eight-year follow-up. N Engl J Med 302:1090PubMedGoogle Scholar
  71. Knehr CA, Beam AG (1956) Psychological impairment in Wilson’s disease. J Nerv Ment Dis 124:251–255PubMedGoogle Scholar
  72. Koehler K (1984) Affective psychopathology in Huntington’s disease: the John Hopkins hypothesis and German psychiatry. Psychol Med 14:733–737PubMedGoogle Scholar
  73. Lakke JPWF, Wilmink JT (1985) A case of Gilles de la Tourette’s syndrome with midbrain involvement. J Neurol Neurosurg Psychiatry 48:1293–1296PubMedGoogle Scholar
  74. Lang AE, Marsden CD (1983) Spasmodic dysphonia in Gilles de la Tourette’s disease. Arch Neurol 40:51–51PubMedGoogle Scholar
  75. Laplane D, Baulac M, Widlöcher D, Dubois B (1984) Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry 47:377–385PubMedGoogle Scholar
  76. Lapouse R, Monk MA (1964) Behaviour deviations in a representative sample of children. Am J Orthopsychiatry 34:436–446PubMedGoogle Scholar
  77. Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106:257–270PubMedGoogle Scholar
  78. Lees AJ, Robertson M, Trimble MR, Murray NMF (1984) A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol Neurosurg Psychiatry 47:1–8PubMedGoogle Scholar
  79. Levine PM, Silberfarb PM, Lipowski ZJ (1978) Mental disorders in cancer patients. Cancer 42:1385–1391PubMedGoogle Scholar
  80. Lewis SW, Mezey GC (1985) Clinical correlates of septum pellucidum cavities: an unusual association with psychosis. Psychol Med 15:43–54PubMedGoogle Scholar
  81. Lipowski ZJ (1978) Organic brain syndromes: areformulation. Compr Psychiatry 19:309–322PubMedGoogle Scholar
  82. Lishman WA (1978) Organic Psychiatry. Blackwells, OxfordGoogle Scholar
  83. Mahendra B (1984) Dementia: a survey of the syndrome of dementia. MTP Press, LancasterGoogle Scholar
  84. Maher ER, Smith EM, Lees AJ (1985) Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 48:1234–1239PubMedGoogle Scholar
  85. Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghels syndrome). J Neurol Neurosurg Psychiatry 39:1204–1209PubMedGoogle Scholar
  86. Marsden CD (1982 a) The mysterious motor function of the basal ganglia: the Robert Warten- berg lecture. Neurology 32:514–539PubMedGoogle Scholar
  87. Marsden CD (1982b) Basal ganglia disease. Lancet 11:1141–1146Google Scholar
  88. Marsden CD, Parkes JD (1973) Abnormal movement disorders. Br J Hosp Med 428–450Google Scholar
  89. Marsden CD, Parkes JD (1976) On-off“effects in patients with Parkinson’s disease in chronic levodopa therapy. Lancet 1:292–296PubMedGoogle Scholar
  90. Marsden CD, Parkes JD (1977) Success and problems of long-term levodopa therapy in Parkinson’s disease. Lancet I:345–349Google Scholar
  91. Marsh GG, Markham CH (1973) Does levodopa alter depression and psychopathology in Parkinsonism patients. J Neurol Neurosurg Psychiatry 36:925–935PubMedGoogle Scholar
  92. Marsh GG, Markham CM, Ansel R (1971) Levodopa’s awakening effect on patients with Parkinsonism. J Neurol Neurosurg Psychiatry 34:209–218PubMedGoogle Scholar
  93. Martin JB (1984) Huntington’s disease. Neurology 34:1059–1072PubMedGoogle Scholar
  94. Marttila RJ, Rinne UK (1976) Dementia in Parkinson’s disease. Acta Neurol Scand 54:431–441PubMedGoogle Scholar
  95. Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment and Parkinson disease. Neurology 31:645–650PubMedGoogle Scholar
  96. McGeer EG, McGeer PL (1976) Duplication of biochemical changes of Huntington’s chorea by intrastriatal injection of glutamic acid and kanaic acids. Nature 263:517–519PubMedGoogle Scholar
  97. Meares R (1971) Natural history of spasmodic torticollis and effect of surgery. Lancet 11:149–150Google Scholar
  98. Mindham RHS (1970) Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry 33:188–191PubMedGoogle Scholar
  99. Mindham RHS, Steele C, Folstein MF, Lucas J (1985) A comparison of the frequency of major affective disorder in Huntington’s disease and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 48:1172–1174PubMedGoogle Scholar
  100. Morphew JA, Sim M (1969) Gilles de la Tourettès syndrome: a clinical and psychopathological study, br J Med Psychol 42:293–301Google Scholar
  101. Moskovitz C, Moses H, Klawans HL (1978) Levodopa — induced psychosis: a kindling phenomenon. Am J Psychiatry 135:669–675PubMedGoogle Scholar
  102. Nee LE, Caine ED, Polinsky RJ, Eldridge R, Ebert MH (1980) Gilles de la Tourette syndrome: clinical and family study of 50 cases. Ann Neurol 7:41–49PubMedGoogle Scholar
  103. Oepen G, Mohr U, Willmes K, Thoden U (1985) Huntington’s disease: visuomotor disturbance in patients and offspring. J Neurol Neurosurg Psychiatry 48:426–433PubMedGoogle Scholar
  104. Ojemann RG, Fisher CM, Adams RD, Sweet WH, New PFJ (1969) Further experience with the syndrome of „normal” pressure hydrocephalus. J Neurosurg 31:279–294PubMedGoogle Scholar
  105. Owens DGC, Johnstone EC, Frith CD (1982) Spontaneous involuntary disorders of movement. Arch Gen Psychiatry 39:452–461PubMedGoogle Scholar
  106. Parkinson J (1817) An essay on the shaking palsy. Sherwood, Neely, Jones, LondonGoogle Scholar
  107. Paterson MT (1945) Spasmodic torticollis: results of psychotherapy in 21 cases. Lancet II:556–559Google Scholar
  108. Perry EK et al. (1985) Cholinergic correlates of cognitive impairment in Parkinson’s disease: comparisons with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 48:413–421PubMedGoogle Scholar
  109. Perry TL, Hansen S, Kloster M (1973) Huntington’s chorea: deficiency of γ-aminobutyric acid in brain. N Engl J Med 288:337–342PubMedGoogle Scholar
  110. Pickard JD (1984) Adult communicating hydrocephalus. In: Harrison MJG (ed) Contemporary neurology, vol 58. Butterworths, London, pp 543–556Google Scholar
  111. Porteous HB, Ross DN (1956) Mental symptoms in Parkinsonism following benzhexol hydrochloride therapy. Br Med J 11:138–140Google Scholar
  112. Rabins PV (1982) Psychopathology of Parkinson’s disease. Compr Psychiatry 23:421–429PubMedGoogle Scholar
  113. Rafal RD, Posner MI, Walker JA, Friedrich FJ (1984) Cognition and the basal ganglia. Brain 107:1083–1094PubMedGoogle Scholar
  114. Rail D, Scholtz C, Swash M (1981) Post-encephalitic Parkinsonism: current experience. J Neurol Neurosurg Psychiatry 44:670–676PubMedGoogle Scholar
  115. Reveley AM, Reveley MA (1983) Aqueduct stenosis and schizophrenia. J Neurol Neurosurg Psychiatry 46:18–22PubMedGoogle Scholar
  116. Riklan M, Weiner H, Diller L (1959) Somato-psychologic studies in Parkinson’s disease. J Nerv Ment Dis 129:263–272Google Scholar
  117. Roberts AH (1969) Brain damage in boxers. Pitman Medical, LondonGoogle Scholar
  118. Robins AH (1976) Depression in patients with Parkinsonism. Br J Psychiatry 128:141–145PubMedGoogle Scholar
  119. Rogers D (1985) The motor disorder of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry 147:221–232PubMedGoogle Scholar
  120. Sacks O (1982) Awakenings. Pan, LondonGoogle Scholar
  121. Schiffer RB, Babigian HM (1984) Behavioral disorders in multiple sclerosis, temporal lobe epilepsy and amyotrophic lateral sclerosis. Arch Neurol 41:1067–1069PubMedGoogle Scholar
  122. Schwab RS, Fabing HD, Prichard JS (1951) Psychiatric symptoms and syndromes in Parkinsons disease. Am J Psychiatry 107:901–907PubMedGoogle Scholar
  123. Scott S, Caird FI, Williams BO (1984) Evidence for an apparent sensory speech disorder in Parkinson’s disease. J Neurol Neurosurg Psychiatry 47:840–843PubMedGoogle Scholar
  124. Sharpe R (1974) Behaviour therapy in a case of blepharospasm. Br J Psychiatry 124:603–604PubMedGoogle Scholar
  125. Sheehy MP, Marsden CD (1982) Writer’s cramp — a focal dystonia. Brain 105:461–480PubMedGoogle Scholar
  126. Sroka H, Elizan TS, Yahr MD, Burger A, Mendoza MR (1981) Organic mental syndrome and confusional states in Parkinson’s disease. Arch Neurol 38:339–342PubMedGoogle Scholar
  127. Steele JC (1972) Progressive supranuclear palsy. Brain 95:693–704PubMedGoogle Scholar
  128. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. Arch Neurol 10:333–359PubMedGoogle Scholar
  129. Stern Y, Langston JW (1985) Intellectual changes in patients with MPTP-induced parkinsonism. Neurology 35:1506–1509PubMedGoogle Scholar
  130. Sweet RD, McDowell FH, Feigenson JS, Loranger AW, Goodell H (1976) Mental symptoms in Parkinson’s disease during chronic treatment with levodopa. Neurology 26:305–310PubMedGoogle Scholar
  131. Sydney Smith J, Kiloh LG (1981) The investigation of dementia: results in 200 consecutive admissions. Lancet 1:824–827Google Scholar
  132. Tibbetts RW (1971) Spasmodic torticollis. J Psychosom Res 15:461–469PubMedGoogle Scholar
  133. Todes CJ, Lees AJ (1985) The pre-morbid personality of patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 48:97–100PubMedGoogle Scholar
  134. Tune LE, Holland A, Folstein MF, Damlovji NF, Gardner TJ, Coyle JT (1981) Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 11:651–652Google Scholar
  135. Villardita C, Smirni P, Le Pira F, Zappala G, Nicoletti F (1982) Mental deterioration, visuoperceptive disabilities and constructional apraxia in Parkinson’s disease. Acta Neurol Scan 66:112–120Google Scholar
  136. Vinken PJ, Bruyn GW (1969–1982) Handbook of clinical neurology. North Holland, AmsterdamGoogle Scholar
  137. Walshe JM (1968) Some observations on the treatment of Wilson’s disease with penicillamine. In: Bergsma D (ed) Birth defects original article series vol 4/2. The National Foundation, New YorkGoogle Scholar
  138. Warburton JW (1967) Depressive symptoms in Parkinson patients referred for thalamotomy. J Neurol Neurosurg Psychiatry 30:368–370PubMedGoogle Scholar
  139. Ward K, Potamianos G, Peters TJ (1984) Essential tremor: a risk factor for alcoholism. Br J Addict 79:451–452PubMedGoogle Scholar
  140. Wilson RS, Kaszniak AW, Klawans HL, Garrón DC (1980) High speed memory scanning in Parkinsonism. Cortex 16:67–72PubMedGoogle Scholar
  141. Wilson SAK (1912) Progressive lenticular degeneration. Brain 34:295–509Google Scholar
  142. Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symptoms. Cambridge University Press, CambridgeGoogle Scholar
  143. Zeman W (1970) Pathology of the torsion dystonias (dystonia musculorum deformans). Neurology 20(11/2):79–88PubMedGoogle Scholar
  144. Zetusky WJ, Jankovic J, Pirozzolo FJ (1985) The heterogeneity of Parkinson’s disease. Neurology 35:522–526PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • J. Cutting

There are no affiliations available

Personalised recommendations